Ponatinib

BNF:

8.1.5

Status:

Red

Decision Date:

None

Comments

RED: NICE TA451 for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia. (Decision date - July 2017)

NHS England drug - to be use in line with NHS England commissioning intentions.

search again